International Union against Tuberculosis and Lung Disease, Paris, France.
Trop Med Int Health. 2010 Jun;15 Suppl 1(s1):70-5. doi: 10.1111/j.1365-3156.2010.02506.x.
The scale-up of antiretroviral therapy (ART) has been one of the success stories of sub-Saharan Africa, where coverage has increased from about 2% in 2003 to more than 40% 5 years later. However, tempering this success is a growing concern about patient retention (the proportion of patients who are alive and remaining on ART in the health system). Based on the personal experience of the authors, 10 key interventions are presented and discussed that might help to improve patient retention. These are (1) the need for simple and standardized monitoring systems to track what is happening, (2) reliable ascertainment of true outcomes of patients lost to follow-up, (3) implementation of measures to reduce early mortality in patients both before and during ART, (4) ensuring uninterrupted drug supplies, (5) consideration of simple, non-toxic ART regimens, (6) decentralization of ART care to health centres and the community, (7) a reduction in indirect costs for patients particularly in relation to transport to and from clinics, (8) strengthening links within and between health services and the community, (9) the use of ART clinics to deliver other beneficial patient or family-orientated packages of care such as insecticide-treated bed nets, and (10) innovative (thinking 'out of the box') interventions. High levels of retention on ART are vital for individual patients, for credibility of programmes and for on-going resource and financial support.
抗逆转录病毒疗法(ART)的推广是撒哈拉以南非洲的成功案例之一,该地区的覆盖率从 2003 年的约 2%增加到 5 年后的 40%以上。然而,人们越来越关注患者的保留率(即仍在卫生系统中接受治疗的存活患者的比例),这对这一成功产生了影响。基于作者的个人经验,提出并讨论了 10 项关键干预措施,这些措施可能有助于提高患者保留率。这些措施包括:(1)需要简单和标准化的监测系统来跟踪情况;(2)可靠地确定失访患者的真实结局;(3)在接受 ART 治疗之前和期间采取措施降低患者的早期死亡率;(4)确保药物供应不间断;(5)考虑简单、无毒的 ART 方案;(6)将 ART 护理下放到卫生中心和社区;(7)降低患者的间接费用,特别是与往返诊所的交通费用相关的费用;(8)加强卫生服务机构内部和之间以及社区内部的联系;(9)利用 ART 诊所提供其他有益的患者或家庭为导向的护理包,如驱虫蚊帐;(10)创新(跳出固有思维)干预措施。高水平的 ART 保留率对个体患者、项目可信度以及持续的资源和财政支持至关重要。